CD4 and cervical carcinoma: This assumption was supported by the lack of reactivity of cord blood naïve CD4+ T cells to peptides corresponding to sequences of the E6 and E7 proteins of the human papilloma virus type-18, which we otherwise showed to be immunogenic in infected healthy individuals and cervical cancer patients [16], [17].